China SXT Pharmaceuticals (SXTC) Change in Account Payables (2018 - 2025)
Historic Change in Account Payables for China SXT Pharmaceuticals (SXTC) over the last 8 years, with Q3 2025 value amounting to $530662.0.
- China SXT Pharmaceuticals' Change in Account Payables fell 6808.49% to $530662.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $530662.0, marking a year-over-year decrease of 6808.49%. This contributed to the annual value of $1.2 million for FY2025, which is 947.37% down from last year.
- Latest data reveals that China SXT Pharmaceuticals reported Change in Account Payables of $530662.0 as of Q3 2025, which was down 6808.49% from $1.2 million recorded in Q1 2025.
- In the past 5 years, China SXT Pharmaceuticals' Change in Account Payables ranged from a high of $1.7 million in Q3 2024 and a low of $530662.0 during Q3 2025
- Moreover, its 5-year median value for Change in Account Payables was $1.4 million (2021), whereas its average is $1.3 million.
- Per our database at Business Quant, China SXT Pharmaceuticals' Change in Account Payables skyrocketed by 2636.12% in 2024 and then plummeted by 6808.49% in 2025.
- Over the past 5 years, China SXT Pharmaceuticals' Change in Account Payables (Quarter) stood at $1.5 million in 2021, then grew by 4.6% to $1.6 million in 2022, then dropped by 15.72% to $1.3 million in 2023, then grew by 26.36% to $1.7 million in 2024, then tumbled by 68.08% to $530662.0 in 2025.
- Its Change in Account Payables was $530662.0 in Q3 2025, compared to $1.2 million in Q1 2025 and $1.7 million in Q3 2024.